The following web links include excellent resources for further information.
A nonprofit organization founded in 1997 by people living with hepatitis C, it provides a wide range of HCV and HCV/HIV information online.
HIV i-Base is an advocacy organization set up in April 2000 by HIV-positive advocates. I-Base produces a monthly publication for doctors and four non-technical treatment guides, all of which are available free, both in print and online.
National AIDS Treatment Advocacy Program (NATAP)
NATAP is a treatment information and advocacy project that provides wide coverage of news about HIV, HCV, HBV, and other related issues. The website and e-mail lists include postings of conference presentations and full journal articles that are otherwise inaccessible due to journal subscription requirements.
NATAP publishes a 40-page HCV/HIV coinfection handbook (last edition, Summer 2005) and other publications that use non-technical language to share detailed information on most important aspects of coinfection. See www.natap.org/2005/publications/ver5final.pdf.
HIV and Hepatitis.com
Medical website that includes research reports on viral hepatitis, particularly as it relates to HIV coinfection. The site is easy to search for articles by subject (e.g., "basics," "new HCV drugs," "biopsy").
Most of the major HIV conferences also include presentations and research relating to HCV/HIV coinfection. Hepatitis conferences tend to be less focused on coinfection.
Many HIV organizations and websites cover reports from these meetings, including NAM (www.aidsmap.com), HIVandHepatitis.com (www.hivandhepatitis.com), HIV i-Base (www.i-base.info), and NATAP (www.natap.org).
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade|
|CROI 2018: Highlights and What's Next for Advocates|
|Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence|
|Injection Drug Use Among People Living With HIV: A Missed Opportunity to Save Lives|
|Statin Use Might Reduce Risk of Cancer in HIV-Positive People|
|Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say|